youtube_live
Q3 2026 earnings • released • EPS beat +0.94% • Revenue beat +1.66%
See resultschevron_right
BSX:NYSE
Boston Scientific Corp
$42.43
arrow_downward
-5.88%(-2.65) 1D
$42.43
0.00% (0.00)
todayPre-market
Closed: Oct 28, 4:00:07 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSX...
Open
$41.95
High
$43.92
Low
$39.57
Mkt. cap
61.49B
Avg. vol.
17.49M
Volume
35.16K
P/E ratio
17.21
52-wk high
$105.65
52-wk low
$39.57
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
Open
$41.95
High
$43.92
Low
$39.57
Mkt. cap
61.49B
Avg. vol.
17.49M
Volume
35.16K
P/E ratio
17.21
52-wk high
$105.65
52-wk low
$39.57
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
News stories
From web sources and news partners
GuruFocus
·
11 minutes ago
Boston Scientific Corp (BSX) (Q3 2026) Earnings Call Highlights:
Benzinga
·
1 hour ago
These Analysts Revise Their Forecasts On Boston Scientific After Q3 Results
Investing.com
·
1 hour ago
Mizuho cuts Boston Scientific stock price target on growth outlook
Yahoo Finance
·
2 hours ago
Boston Scientific (BSX) Could Be 27% Below Fair Value After Earnings Guidance Cut
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com